Microfibrillar collagen model of canine cerebral infarction

P. D. Purdy, M. D. Devous, H. H. Batjer, C. L. White, Y. Meyer, D. S. Samson

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

A new canine model of focal cerebral ischemia has been developed employing intravascular delivery of microfibrillar collagen via femoral catheterization. In 13 dogs, dose-effect studies showed neurologic deficits (ranging from mild hemiparesis to death) related to the dose of microfibrillar collagen delivered. In another 10 dogs, 0.5 ml of 60 mg/ml microfibrillar collagen was injected into the common carotid artery; neurologic assessment over 48 hours revealed a survivable stroke syndrome in seven dogs, death at 40 hours in one dog and at <12 hours in another, and no clinical effect in one dog. The eight surviving dogs were sacrificed at 48 hours; nine of the 10 dogs had middle cerebral artery distribution infarcts (two grossly hemorrhagic and five grossly nonhemorrhagic) on histologic examination. Angiography in three dogs demonstrated no significant major vascular occlusion. All seven dogs with survivable strokes demonstrated a dense hemiparesis at 24 hours that improved to ambulatory status at 48 hours. The use of microfibrillar collagen to produce middle crebral artery strokes in dogs provides a new opportunity to study cerebral ischemia without surgery involving the cervical or cranial vasculature. Dogs have larger brains than other common animal models and thus are more amenable to study with imaging modalities. A model with a measurable but survival insult provides an opportunity for short- and long-term clinical follow-up and for the investigation of therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)1361-1367
Number of pages7
JournalStroke
Volume20
Issue number10
StatePublished - 1989

Fingerprint

Cerebral Infarction
Canidae
Collagen
Dogs
Stroke
Paresis
Brain Ischemia
Common Carotid Artery
Middle Cerebral Artery
Neurologic Manifestations
Thigh
Catheterization
Nervous System
Blood Vessels
Angiography
Animal Models
Arteries

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Purdy, P. D., Devous, M. D., Batjer, H. H., White, C. L., Meyer, Y., & Samson, D. S. (1989). Microfibrillar collagen model of canine cerebral infarction. Stroke, 20(10), 1361-1367.

Microfibrillar collagen model of canine cerebral infarction. / Purdy, P. D.; Devous, M. D.; Batjer, H. H.; White, C. L.; Meyer, Y.; Samson, D. S.

In: Stroke, Vol. 20, No. 10, 1989, p. 1361-1367.

Research output: Contribution to journalArticle

Purdy, PD, Devous, MD, Batjer, HH, White, CL, Meyer, Y & Samson, DS 1989, 'Microfibrillar collagen model of canine cerebral infarction', Stroke, vol. 20, no. 10, pp. 1361-1367.
Purdy PD, Devous MD, Batjer HH, White CL, Meyer Y, Samson DS. Microfibrillar collagen model of canine cerebral infarction. Stroke. 1989;20(10):1361-1367.
Purdy, P. D. ; Devous, M. D. ; Batjer, H. H. ; White, C. L. ; Meyer, Y. ; Samson, D. S. / Microfibrillar collagen model of canine cerebral infarction. In: Stroke. 1989 ; Vol. 20, No. 10. pp. 1361-1367.
@article{d039d1c80af4492bb61ac77bc798f2ac,
title = "Microfibrillar collagen model of canine cerebral infarction",
abstract = "A new canine model of focal cerebral ischemia has been developed employing intravascular delivery of microfibrillar collagen via femoral catheterization. In 13 dogs, dose-effect studies showed neurologic deficits (ranging from mild hemiparesis to death) related to the dose of microfibrillar collagen delivered. In another 10 dogs, 0.5 ml of 60 mg/ml microfibrillar collagen was injected into the common carotid artery; neurologic assessment over 48 hours revealed a survivable stroke syndrome in seven dogs, death at 40 hours in one dog and at <12 hours in another, and no clinical effect in one dog. The eight surviving dogs were sacrificed at 48 hours; nine of the 10 dogs had middle cerebral artery distribution infarcts (two grossly hemorrhagic and five grossly nonhemorrhagic) on histologic examination. Angiography in three dogs demonstrated no significant major vascular occlusion. All seven dogs with survivable strokes demonstrated a dense hemiparesis at 24 hours that improved to ambulatory status at 48 hours. The use of microfibrillar collagen to produce middle crebral artery strokes in dogs provides a new opportunity to study cerebral ischemia without surgery involving the cervical or cranial vasculature. Dogs have larger brains than other common animal models and thus are more amenable to study with imaging modalities. A model with a measurable but survival insult provides an opportunity for short- and long-term clinical follow-up and for the investigation of therapeutic interventions.",
author = "Purdy, {P. D.} and Devous, {M. D.} and Batjer, {H. H.} and White, {C. L.} and Y. Meyer and Samson, {D. S.}",
year = "1989",
language = "English (US)",
volume = "20",
pages = "1361--1367",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Microfibrillar collagen model of canine cerebral infarction

AU - Purdy, P. D.

AU - Devous, M. D.

AU - Batjer, H. H.

AU - White, C. L.

AU - Meyer, Y.

AU - Samson, D. S.

PY - 1989

Y1 - 1989

N2 - A new canine model of focal cerebral ischemia has been developed employing intravascular delivery of microfibrillar collagen via femoral catheterization. In 13 dogs, dose-effect studies showed neurologic deficits (ranging from mild hemiparesis to death) related to the dose of microfibrillar collagen delivered. In another 10 dogs, 0.5 ml of 60 mg/ml microfibrillar collagen was injected into the common carotid artery; neurologic assessment over 48 hours revealed a survivable stroke syndrome in seven dogs, death at 40 hours in one dog and at <12 hours in another, and no clinical effect in one dog. The eight surviving dogs were sacrificed at 48 hours; nine of the 10 dogs had middle cerebral artery distribution infarcts (two grossly hemorrhagic and five grossly nonhemorrhagic) on histologic examination. Angiography in three dogs demonstrated no significant major vascular occlusion. All seven dogs with survivable strokes demonstrated a dense hemiparesis at 24 hours that improved to ambulatory status at 48 hours. The use of microfibrillar collagen to produce middle crebral artery strokes in dogs provides a new opportunity to study cerebral ischemia without surgery involving the cervical or cranial vasculature. Dogs have larger brains than other common animal models and thus are more amenable to study with imaging modalities. A model with a measurable but survival insult provides an opportunity for short- and long-term clinical follow-up and for the investigation of therapeutic interventions.

AB - A new canine model of focal cerebral ischemia has been developed employing intravascular delivery of microfibrillar collagen via femoral catheterization. In 13 dogs, dose-effect studies showed neurologic deficits (ranging from mild hemiparesis to death) related to the dose of microfibrillar collagen delivered. In another 10 dogs, 0.5 ml of 60 mg/ml microfibrillar collagen was injected into the common carotid artery; neurologic assessment over 48 hours revealed a survivable stroke syndrome in seven dogs, death at 40 hours in one dog and at <12 hours in another, and no clinical effect in one dog. The eight surviving dogs were sacrificed at 48 hours; nine of the 10 dogs had middle cerebral artery distribution infarcts (two grossly hemorrhagic and five grossly nonhemorrhagic) on histologic examination. Angiography in three dogs demonstrated no significant major vascular occlusion. All seven dogs with survivable strokes demonstrated a dense hemiparesis at 24 hours that improved to ambulatory status at 48 hours. The use of microfibrillar collagen to produce middle crebral artery strokes in dogs provides a new opportunity to study cerebral ischemia without surgery involving the cervical or cranial vasculature. Dogs have larger brains than other common animal models and thus are more amenable to study with imaging modalities. A model with a measurable but survival insult provides an opportunity for short- and long-term clinical follow-up and for the investigation of therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=0024357428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024357428&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 1361

EP - 1367

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 10

ER -